GlassScriptPhysician profile
Carol S Moss
NPI 1548378144
$432.97
in general payments reported to CMS, 2019-2025
12 companies · $147 in 2025
The $147 reported for 2025 was more than what a typical Pediatric Radiology provider received nationally (typical 2025 total: $141).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.46 · 2020: $46.61 · 2021: $105 · 2022: $76.32 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $116.29 | 2025 | Gel Mark Ultracor Breast Tissue Marker |
| Puma Biotechnology, INC. | $55.57 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $44.62 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.85 | 2019 | |
| Hologic Sales and Service, LLC | $30.27 | 2025 | 3dimensions, 3dquorum |
| Bayer Healthcare Pharmaceuticals INC. | $27.02 | 2020-2021 | |
| Blueprint Medicines Corporation | $25.01 | 2021 | |
| Karyopharm Therapeutics INC. | $21.67 | 2021 | |
| Alexion Pharmaceuticals, INC. | $21.61 | 2019 | |
| Amgen INC. | $20.75 | 2022 | |
| Mylan Institutional INC. | $17.72 | 2020 | |
| Seagen INC. | $15.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carol Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.